/Companies

MOST Cardio

Salem, US · Founded 2017 · Delaware LLC

Find your way into MOST Cardio

Sign up to see every warm intro you have to MOST Cardio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MOST Cardio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Most Cardio develops cardiovascular surgical instrumentation using a reposable design platform (reusable handles with disposable end effectors) combined with micro-robotics and nanotechnology to emulsify and remove arterial plaque via minimally invasive procedures. Its products, including a robotic control station, catheters, micro-emulsifiers, extractor wires and MIS access ports, target clinicians at hospitals and surgery centers as alternatives to stents, angioplasty and heart bypass surgery.

Founders & leadership

HD
Henri De GuillebonNamed on SEC filing
RM
Robert MennNamed on SEC filing
AS
Alec SternNamed on SEC filing
PM
Pavel MennNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$600K disclosed across 1 round · 2017

▶$600KraisedSep 2017 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Henri De GuillebonDirector
  • Robert MennDirector
  • Alec SternDirector
  • Pavel MennExecutive Officer
Offering amount
$5M
Amount sold
$600K
First sale
Aug 2017
Incorporated
Limited Liability Company, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does MOST Cardio do?
Most Cardio develops cardiovascular surgical instrumentation using a reposable design platform (reusable handles with disposable end effectors) combined with micro-robotics and nanotechnology to emulsify and remove arterial plaque via minimally invasive procedures. Its products, including a robotic control station, catheters, micro-emulsifiers, extractor wires and MIS access ports, target clinicians at hospitals and surgery centers as alternatives to stents, angioplasty and heart bypass surgery.
How much funding has MOST Cardio raised?
MOST Cardio has disclosed $600K raised across 1 round.
Where is MOST Cardio headquartered?
MOST Cardio is headquartered in Salem, US.